PUK6 ECONOMIC IMPACT OF EXTENDED-RELEASE TOLTERODINE VERSUS IMMEDIATE-AND EXTENDED-RELEASE OXYBUTYNIN AMONG COMMERCIALLY-INSURED PERSONS WITH OVERACTIVE BLADDER
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67383-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)67383-4/fulltext
Section Title :
Section Order :
622
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67383-4&doi=10.1016/S1098-3015(10)67383-4